Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter, Orchid Sue Sequenom for Patent Infringement

NEW YORK (GenomeWeb News) – Beckman Coulter and Orchid Cellmark have filed a lawsuit against Sequenom in the US District Court for the Southern District of California, alleging that Sequenom is infringing certain patents owned by Orchid and licensed to Beckman.
Beckman and Orchid allege in the complaint filed last week that Sequenom’s MassArray iPlex products for SNP genotyping applications infringe three patents owned by Orchid that were licensed to Beckman in December 2002. The three patents — US Nos. 6,004,744; 5,888,819; and 6,004,744 — cover methods of use and reagents used for genotyping applications, which are part of Beckman’s GenomeLab SNPstream Genotyping System.
Beckman and Orchid claim in the lawsuit that Sequenom was informed twice earlier this year that its products infringe the ‘819 and ‘744 patents.
The firms have asked the court to permanently enjoin Sequenom from selling products that they believe infringe the three patents. They also are seeking damages for lost profits and costs associated with the lawswuit.
Sequenom said in a filing with the US Securities and Exchange Commission yesterday that it believes “the plaintiffs’ claims are without merit and will vigorously defend against the claims advanced in the complaint.”
In early Tuesday trade on the Nasdaq, Sequenom’s shares were down 5.5 percent at $12.13.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.